Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

Researchers from Insmed Inc. presented findings on INM-901, a novel synthetic cannabinoid analogue, demonstrating its effects ...

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Parkinson’s disease affects over 10 million people worldwide ... The University of Sydney researchers created a mouse model that mimics this copper-deficient brain environment. These “SOCK” mice, as ...

Mice don't get Alzheimer's -- and while that's good news for mice, it's a big problem for biomedical researchers seeking to understand the disease and test new treatments. Now, researchers at The ...

Bernardo, A. M., et al. (2025). Procognitive and neurotrophic benefits of α5-GABA-A receptor positive allosteric modulation in a β-amyloid deposition mouse model of Alzheimer’s disease pathology.

AnimalResearch is an essential part of the drug discovery process - they help us test new treatments, and could help change ...

A new way to combat Alzheimer’s disease has been discovered by researchers at the RIKEN Center for Brain Science (CBS) in Japan. Using mice with the disease, the researchers found that treatment ...

Oblak, Howell, and colleagues are involved in the Model Organism Development and Evaluation for Late-Onset Alzheimer’s disease (MODEL-AD) consortium, creating new mouse strains that carry combinations ...